Exela Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XELA research report →
Range $70 – $70
Price Chart
About the company
Exela Technologies, Inc. delivers a range of business solutions globally, focusing on transaction processing, managing enterprise information, document handling, and digitalizing business operations. The company organizes its services across three primary divisions: Information & Transaction Processing Solutions (ITPS), Healthcare Solutions (HS), and Legal & Loss Prevention Services (LLPS).
- CEO
- Suresh Yannamani
- IPO
- 2015
- Employees
- 12,600
- HQ
- Irving, TX, US
Get TickerSpark's AI analysis on XELA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $55.50K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- 3.98
- Div Yield
- 0.00%
- Gross Margin
- 24.58%
- Op Margin
- 6.00%
- Net Margin
- -8.66%
- ROE
- 2.82%
- ROIC
- 32.99%
Latest fiscal year · YoY change
- Revenue
- $142.77M-86.6%
- Gross Profit
- $35.10M-84.8%
- Op Income
- $8.57M
- Net Income
- $-12,366,000+90.1%
- EPS
- $-0.41+98.2%
- OCF Growth
- -247.0%
- FCF Growth
- +22.2%
- 52W High
- $0.20
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.02
- Beta
- 5.14
- RSI (14)
- 45
- Avg Volume
- 2.38K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Exela reported a smaller Q1 loss and slightly higher gross margin as revenue fell, but management said renewals, new logo wins, and cost actions are helping stabilize the business.· May 28, 2024
- Q1 revenue was $258.8 million, down 5.4% year over year, or down 4.3% pro forma after the high-speed scanner sale.
- Gross margin was 22%, up 17 basis points year over year, with Healthcare and LLPS margins improving meaningfully.
- Net loss improved to $25.6 million, about $20 million better than last year, helped by lower interest and debt expense.
- Adjusted EBITDA was $12.9 million, while SG&A fell 43 basis points year over year.
- Management highlighted a 96% renewal rate in Q1, 85 new logo wins, and ongoing real estate consolidations to support margin improvement.
First quarter revenue was $258.8 million, down 5.4% year over year, or down 4.3% pro forma for the sale of the high-speed scanner business. Gross margin was 22%, up 17 basis points year over year. Net loss was $25.6 million, an improvement of $20 million year over year, and adjusted EBITDA was $12.9 million. On a segment basis, Information and Transaction Processing Solutions declined 9% year over year, Healthcare Solutions grew about 3% to 4%, and Legal and Loss Prevention Services grew about 6% year over year, though LLPS was down 12% sequentially due to project fluctuations. Looking ahead, management did not give formal quarterly or full-year financial guidance, but said it expects continued margin improvement, revenue stabilization, and liquidity progress through 2024.
The call did not include the CEO, so the strategic commentary came from interim CFO Matt Brown. His message was that Exela is pushing revenue stabilization while improving profitability through automation, operational leverage, and a shift from CapEx to OpEx as data center infrastructure moves to the cloud. He sounded cautiously optimistic, saying the company is making good progress on savings initiatives and remains focused on strategic growth areas such as Reaktr.ai.
Matt Brown emphasized several financial improvements: gross margin reached 22%, SG&A fell 43 basis points year over year, current liabilities were down 23%, and interest expense was down 52% year over year. He also said the net loss improved to $25.6 million and adjusted EBITDA was $12.9 million. On liquidity, he noted unrestricted cash of approximately $10 million after the interest payment and said the company is pursuing financing initiatives while managing rising taxes as NOLs are reduced.
There was no analyst Q&A on the call. The operator opened the line for questions, but no questions were asked, so there were no additional management answers or follow-up concerns discussed.
The positive case from this call is that Exela is showing signs of stabilization even after the loss of a $27 million low-margin contract. Management pointed to a 96% renewal rate, 85 new logo wins, improving margins in Healthcare and LLPS, and multiple cost actions, including real estate consolidation and lower interest expense.
The main risks are still clear: revenue declined year over year, ITPS fell after the contract exit, LLPS was down sequentially, and unrestricted cash was only about $10 million after the interest payment. Management also flagged rising taxes as NOLs shrink and said financing initiatives are still in progress, which suggests liquidity remains a concern.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 36.0%
- Shares Outstanding
- 27.75M
- Float Shares
- 10.00M
of shares held by institutions
22 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock Inc. | 41.98K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 21, 24 | CHADHA PAR | other | 354 |
| Nov 21, 24 | CHADHA PAR | other | 7 |
| Nov 21, 24 | CHADHA PAR | other | 8 |
| Nov 21, 24 | CHADHA PAR | other | 5,473,231 |
| Nov 21, 24 | CHADHA PAR | other | 9,452,256 |
| Nov 21, 24 | CHADHA PAR | other | 4,818,439 |
| Nov 21, 24 | CHADHA PAR | sell | 5,473,231 |
| Nov 21, 24 | CHADHA PAR | sell | 1,979,025 |
| Nov 21, 24 | CHADHA PAR | other | 8,713 |
| Nov 21, 24 | CHADHA PAR | other | 551,723 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our XELA coverage
Recent articles, reports, and earnings notes.
No research on XELA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XELA report →Reviewing Exela Technologies (NASDAQ:XELA) & Waitr (NASDAQ:ASAP)
defenseworld.net · Jan 3
Financial Contrast: Exela Technologies (NASDAQ:XELA) vs. Waitr (NASDAQ:ASAP)
defenseworld.net · Dec 31
Exela Technologies Announces Strategic Partnership with Michael Page
globenewswire.com · Jan 28
Exela Technologies, Inc. Announces Intention to Delist its Securities from Nasdaq and to Deregister its Securities under the Securities Exchange Act
globenewswire.com · Jan 7
Exela Technologies Recognized as a Strong Performer in Industry-Leading Task-Centric Automation Software Report
globenewswire.com · Dec 19
Exela Technologies, Inc. (XELA) Q3 2024 Earnings Call Transcript
seekingalpha.com · Nov 29
Exela Technologies, Inc. to Host Third Quarter 2024 Financial Results Conference Call
globenewswire.com · Nov 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.